Maintenance / Service
PRODUCTS
-
TrialScope Disclose is the industry’s most trusted and comprehensive clinical trial disclosure solution. Simplify, centralize, and gain complete control of your entire global disclosure process from trial planning to results submission, ensuring full transparency and regulatory disclosure compliance at every stage.
-
Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.
-
At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.
-
PHCbi brand's 25.7 cu.ft (729L) ultra-low temperature freezer operates on 220V and features VIP Plus vacuum insulated panels to deliver reliable temperature uniformity throughout the chamber. It is ENERGY STAR® Certified and uses only 7.96Wh per day.
-
Several of our recent Life Sciences podcasts have featured conversations about the rapid shifts taking place in this dynamic industry. Automation and information management technology are rapidly advancing to help address these challenges.
WHITE PAPERS AND CASE STUDIES
-
Enhancing Clinical Trial Flexibility
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
Office Of Naval Research Contract Leads To New Chlorine Sensor Technology
Developed from U.S. Office of Naval Research requirements, this multiparameter chlorine sensor offers extended maintenance-free operation, flow-independence, and automatic compensation for reliable, in-pipe monitoring.
-
Endpoint Clinical RTSM: Getting The Job Done
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
Novel Platform For Execution Of Pragmatic Studies Boosts Cancer Trial Efficiency
Learn how Flatiron partnered with Genentech and Foundation Medicine to develop a novel platform for the execution of pragmatic studies.
-
Operational Success By Strategic Investment
Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.
-
Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories
Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.
-
Pave The Way To High Productivity With Continuous Manufacturing For Pharma
Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.
-
Verve Puts Digital-First Quality At The Heart Of Its QC Lab
Learn how a biotech scaled faster by building a paperless lab, adopting cloud-based LIMS, and streamlining QA/QC processes to reduce errors, improve efficiency, and enable real-time collaboration.
-
Advancing Multiomics Through Intelligent Automation
Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.
-
Facility-Fit-Driven Process Development For A Monoclonal Antibody
See how proactively designing around plant constraints, using high-capacity resins, and leveraging parallel workstreams resulted in a 50% reduction in processing hours and 25% lower costs.
-
Global Start-Up For Multinational Geographic Atrophy Trial
This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.
NEWS
-
UQAM RFID-IoT Lab Partners With RF Controls And Tego Inc. To Revolutionize Work-In-Progress Tracking In Manufacturing6/25/2025
The Université du Québec à Montréal (UQAM) RFID-IoT Lab today announced its strategic collaboration with RF Controls and Tego Inc. to develop an advanced solution for improving operational efficiency and visibility in work-in-progress (WIP) management across aerospace, defense, and other discrete manufacturing sectors.
-
Artificio Processes Documents In 80+ Languages, Enabling Multinational Corporations To Automate Global Operations12/9/2025
Artificio Products Inc., a leader in AI-powered intelligent document processing and enterprise workflow automation, today announced that its platform now processes documents in more than 80 languages, positioning the company as a comprehensive solution for multinational corporations managing cross-border document operations.
-
Fischer Mechanical Partners With Byrne Software And Runding Corporation To Modernize Project Delivery And Field Operations8/19/2025
Fischer Mechanical, a fast growing St. Louis-based mechanical contractor, has selected Byrne Software Technologies in partnership with Runding Corporation to support its digital transformation initiative aimed at improving labor productivity, standardizing workflows, and enabling real-time job cost insights.
-
TimeForge Joins Square's Ecosystem To Make Managing Teams Easier Than Ever7/14/2025
TimeForge, the leading provider of labor management solutions for the retail and foodservice industries, is excited to announce its partnership and integration with Square, the technology company that makes commerce and finance services easy and accessible.
-
ITM And Alpha-9 Oncology Enter Into Supply Agreement For Therapeutic Medical Radioisotope Actinium-2254/24/2025
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical-stage biotechnology company advancing a distinctive portfolio of differentiated and highly targeted radiopharmaceuticals, today announced the signing of a supply agreement for Actinium-225 (Ac-225) to support the development of Alpha-9’s radiopharmaceutical programs.